by Shaoxing Chen, Xiaohuang Yang, Shaona Jiang, Yina Lin, Leijuan Huang, Huiqin Chen, Jinzhu Zheng, Yuanfu Xie, Zhixing Kuang Background Female-specific cancers represent a substantial public health challenge in China. This study was designed to evaluate temporal trends and generate future projections of the burden associated with female-specific cancers in China from 1990 to 2023.
Methods Data on incidence, mortality, and disability-adjusted life-years (DALYs) attributable to breast, cervical, uterine, and ovarian cancers among women in China were extracted from the Global Burden of Disease (GBD) 2023 database. Joinpoint analysis was used to assess temporal trends, whereas decomposition analysis was applied to quantify the contributions of epidemiological changes, population growth, and ageing to changes in disease burden; a Bayesian age-period-cohort (BAPC) model was further used to project trends in disease burden over the next 15 years.
PLOS ONE (Medicine) published a clinical update in Research Highlights on 10 Jun 2026.
The item focuses on Burden and temporal trends of female-specific cancers in China: A systematic analysis of the 2023 global burden of disease study.
Review the original article for the full source wording and details.